Haleon PLC (LSE:HLN, NYSE:HLN) has unveiled pricing for a near £1 billion bond offering set to be carried out by its subsidiary this month.
Some €750 million (£633 million) worth of Euro medium-term notes to mature in 2028 will be sold with a price of 2.875%, the FTSE 100-listed health firm announced Thursday.
An additional £300 million notes due to mature in 2033 with fixed rates of 4.625% will also be offered, the company added.
Proceeds from these will in part be used to repay a US$1.75 billion (£1.34 billion) bond maturing next March, alongside for corporate purposes.
The offering, carried out by subsidiary Haleon UK Capital, is set to close on September 18, with the notes being registered to the international securities market in London.
Haleon shares dipped 0.3% on Thursday.